-+ 0.00%
-+ 0.00%
-+ 0.00%

Cocrystal Pharma Q1 EPS $(0.23) Beats $(0.51) Estimate

Benzinga·05/15/2025 12:18:35
Listen to the news
Cocrystal Pharma (NASDAQ:COCP) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.51) by 54.9 percent. This is a 41.03 percent increase over losses of $(0.39) per share from the same period last year.